Market: NYQ |
Currency:
Address:
📈 RVI Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
-
-
Upside/Downside from Analyst Target:
-
-
Broker Call:
-
-
Dividend Minimum 3 Year Yield:
-
-
EPS Growth Range (1Y):
-
-
Net Income Growth Range (1Y):
-
-
Revenue Growth Range (1Y):
-
-
Upcoming Earnings Date:
-
💰 Dividend History
No dividend history available.
📅 Earnings & EPS History for RVI
No earnings history available for this symbol.
📰 Related News & Research
-
Encore Medical IPO: Innovative PFO Closure Device Targets $1.5B Stroke & $100B Migraine Markets | Investment Opportunity & Clinical Trials Overview 2491018
April 5, 2026
Encore Medical, Inc. IPO: Investor-Grade Analysis, Financial...
-
AMS Advanced Material Berhad IPO 2026: Company Overview, Business Model, Key Management & Investment Insights
April 5, 2026
AMS Advanced Material Berhad IPO: Comprehensive Investor Gui...
-
Leading TCM Healthcare Services in China: Tong Ren Tang’s Expansion, Competitive Strengths, and Future Strategies Explained
April 5, 2026
Yiyang Tongrentang: Hong Kong IPO Analysis, Offer Details, F...
-
Hebei Keli Automotive Equipment Co., Ltd. 2025 Annual Report Summary – Financial Data, Business Overview, Industry Analysis and Shareholder Information
April 5, 2026
河北科力汽车装备股份有限公司2025年度报告深度解读 河北科力汽车装备股份有限公司2025年度报告深度解读 报告要点...
-
Acuity Inc. Q2 2026 10-Q Report: Financial Results, Segment Overview, and Business Highlights
April 4, 2026
Acuity Inc. Q2 2026 Earnings Report: Key Highlights and Anal...
-
AngioDynamics Inc. Q3 2026 Financial Results: Revenue, Net Loss, and Key Financial Statements Overview
April 4, 2026
AngioDynamics, Inc. Reports Q3 2026 Financial Results: Key H...
-
Revenue, Cost of Services, and Financial Performance Breakdown Across Business Segments
April 4, 2026
RCM Technologies, Inc. Reports Fiscal 2024 Results: Key High...
-
Fidelity National Information Services, Inc. (FIS) 8-K Filing Details Senior Notes and NYSE Listings – March 30, 2026
April 4, 2026
Fidelity National Information Services, Inc. (FIS) 8-K Repor...
-
Skye Bioscience Signs Master Services Agreement With Lohman & Associates for Finance and Accounting Consulting
April 4, 2026
Skye Bioscience, Inc. - Detailed Investor Report Skye Bi...
-
Crown Reserve Acquisition Corp. I and Carvix, Inc. Announce $1 Billion Business Combination Agreement and Nasdaq Listing Plans
April 4, 2026
Crown Reserve Acquisition Corp. I – Key Developments and Inv...
🔍 View more Reports